TAK logo

TAK CapEx to Revenue

Latest reported4.41%
TAK Quarterly CapEx/Revenue (0.00% → 4.41%)
High-resolution chart · PNG

TAK capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.4111%
4.2357%
3.4936%
4.7471%
4.3294%
4.632%
3.9408%
4.2068%
4.7551%
4.238%
4.2369%
3.6284%
4.3412%
3.7409%
3.0518%
2.9231%
4.3318%
4.0741%
3.0037%
3.6414%
3.1422%
4.6951%
2.9354%
3.4659%
2.8852%
4.8253%
4.0453%
3.1101%
3.5165%
3.8054%
2.6171%
4.1105%
4.3587%
4.5969%
2.5136%
5.091%
3.1791%
4.6501%
3.2365%
3.6558%
3.3223%
5.8244%
4.3791%
5.1801%
3.4959%
5.2302%
5.4589%
4.3473%
9.7306%
5.6214%
4.6846%
4.6618%
3.6059%
0%
0%
0%
0%
0%
0%
0%
0%
3.7631%
7.1721%
10.2511%
13.6093%
9.7273%
7.3175%
4.8319%
2.2777%
2.7255%
1.5012%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.